DB

Ben Tre Pharmaceutical JSC

DBT · VN · Healthcare / Drug Manufacturers - Specialty & Generic

12,800.00VND+650.47 (+5.35%)

Price History

Full chart

Market Stats

Previous Close12,149.53
Open12,800.00
Day Range12,800.00 – 12,800.00
52-Week Range9,990.00 – 13,900.00
Volume10.10K
Market Cap289.97B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.34
50-Day Avg13,153.00
200-Day Avg11,821.25

About

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, anti-inflammatory, on-site impact, and diabetics, as well as herbal medicines. It offers supplements and medical devices. The company was founded in 1963 and is headquartered in Ben Tre, Vietnam.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Hanh Khac Nguyen
  • Employees614
  • Headquarters6A3, 60 National Highway, Ben Tre, Vietnam, Vietnam
  • Websitehttps://www.bepharco.com

Leadership

  • Mr. Hanh Khac NguyenGeneral Director · b. 1978
  • Ms. Dung thuy NguyenChief Accountant
  • Mr. Duong Thai NguyenHR Director & Director
  • Mr. Hoang Son NguyenHead of Internal Audit

Earnings

Report DateDec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------
EPS Actual294.81-16.61205.477.55741.19193.851219.94307.75228.27507.09-88.8235.61313.23371.4146.60102.10193.93120.89471.3726.31115.75705.29434.20
Surprise-----------------------
Timing-----------------------

Key Statistics & Ratios

Market Cap289.97B
Enterprise Value296.56B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.33
Price / Book0.00
Book Value13,015.48
Revenue (TTM)873.41B
Gross Profit (TTM)336.17B
EBITDA63.00B
Profit Margin3.24%
Operating Margin10.40%
Return on Equity9.84%
Return on Assets3.09%
Shares Outstanding21.97M
Shares Float7.09M
Beta0.34
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
521.69Feb 19, 2021

Stock Splits

  • Nov 13, 2026107:100
  • Sep 19, 2025107:100
  • Jul 5, 202457:50
  • Jan 30, 202311:10
  • Jan 5, 202121:20